Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
FDA approval · 2016-07-14FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic zoledronic acid product from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals)…
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating epoetin alfa for chemotherapy-induced anemia has completed, with an update summarizing trial status across multip…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated omega-3 fatty acids for advanced cancer patients with significant weight loss; the study has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma [EARLY_Phase 1]
The clinical trial NCT02447055 evaluating allogeneic stem cell transplantation for multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma [Phase 4]
Phase 4 pharmacokinetic study of bortezomib conducted in Taiwanese patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment [Phase 3]
Phase 3 trial evaluating ondansetron for chronic nausea and vomiting in patients with advanced cancer not caused by cancer treatment; the st…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM [Phase 1]
Phase I trial evaluating the combination of bortezomib (Velcade) and pralatrexate in relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating peripheral stem cell transplantation in adults with multiple myelo…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [NA]
This terminated clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation followed by cyc…
-
CLINICAL_TRIALS research · 2016-06-24Clinical Trial Update: Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
Clinical trial update on autologous stem cell transplantation for newly diagnosed multiple myeloma patients over 65; current status of the t…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
This Phase II trial evaluated a regimen of Revlimid (lenalidomide) with oral cyclophosphamide and prednisone in newly diagnosed multiple mye…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma [Phase 1]
Phase 1 trial evaluating the combination of lenalidomide with autologous mature dendritic cells pulsed with KRN7000 in multiple myeloma; the…
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure
This is an observational registry study documenting real-world treatment of multiple myeloma without any investigational drugs; the study st…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT [Phase 2, Phase 3]
Clinical trial update on assessing molecular remission by ASO-qPCR after bortezomib-dexamethasone induction followed by autologous stem cell…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma [Phase 3]
Phase 3 safety confirmation study of lenalidomide with dexamethasone in Japanese patients with previously treated multiple myeloma completed…
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.
A clinical trial update examining bortezomib as a first salvage therapy for multiple myeloma patients who were previously exposed to bortezo…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Lenalidomide and High-Dose Melphalan [Phase 1, Phase 2]
Clinical trial update on lenalidomide with high-dose melphalan for patients with multiple myeloma undergoing stem cell transplantation. The …
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
FDA approval · 2016-06-03FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
The FDA approved a supplemental application for KYPROLIS (carfilzomib) from Onyx Pharmaceuticals, Inc. This action updates the drug’s labeli…